About This Fund
3 Boomerang Capital I, L.P. is a healthcare-focused private equity fund targeting the lower middle market, managed by 3 Boomerang Capital (3BC), a Greenwich, Connecticut–based firm founded in 2023 by Adam Dolder and Adam Elberg. Both founders bring prior careers as both healthcare investors and healthcare entrepreneurs — a dual background the firm describes as fundamental to its differentiated approach. 3BC focuses exclusively on founder-led businesses in the healthcare sector, providing not only capital but operational guidance drawn from firsthand experience scaling and managing healthcare enterprises. The firm operates with an eleven-person team structured to provide hands-on engagement with portfolio companies.
3 Boomerang Capital I targets four sub-sectors within healthcare: BioPharma outsourcing (contract research, manufacturing, and laboratory services), medical device and diagnostic manufacturing, information technology and tech-enabled services for healthcare, and alternate site care (outpatient, home health, and specialty clinic settings). The fund targets lower middle market businesses — typically generating $10M–$100M in revenue — where management depth, succession planning, and operational systems can benefit from private equity partnership. Geographic focus spans North America and select Western European markets with established healthcare infrastructure.
Fund I surpassed its $350 million target, closing above $375 million of total commitments from a diversified LP base including leading endowments, foundations, pension funds, insurance companies, fund-of-funds, and family offices, in addition to 3BC professionals. The final close was announced on February 6, 2024. Initial portfolio activity includes a growth recapitalization of Professional Physical Therapy (ProPT), described as the largest outpatient physical therapy business in the Northeastern United States. The successful above-target close on its inaugural fund validates the founding team's thesis that founder-aligned, healthcare-specialist private equity is a durable and differentiated strategy in the lower middle market.